Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16669.7China
BN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used